{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:05:58Z","timestamp":1773860758370,"version":"3.50.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T00:00:00Z","timestamp":1461715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2012ZX10001-002 and 2009DFB30420"],"award-info":[{"award-number":["2012ZX10001-002 and 2009DFB30420"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Chinese State Key Laboratory of Infectious Disease Develop Grant, and the International Development Research Center of Canada","award":["grant #104519-010"],"award-info":[{"award-number":["grant #104519-010"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0154421","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T17:47:34Z","timestamp":1461779254000},"page":"e0154421","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China"],"prefix":"10.1371","volume":"11","author":[{"given":"Jing","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiafeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingjie","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,4,27]]},"reference":[{"key":"ref1","first-page":"989","article-title":"Pharmacologic considerations for therapeutic success with antiretroviral agents","volume":"33","author":"CV Fletcher","year":"1999"},{"issue":"Suppl 1","key":"ref2","first-page":"S61","article-title":"Attaining higher goals in HIV treatment: the central importance of adherence","volume":"13","author":"GH Friedland","year":"1999"},{"key":"ref3","first-page":"239","article-title":"Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods","volume":"11","author":"F Marcellin","year":"2013"},{"key":"ref4","first-page":"696","article-title":"Hair it is: the long and short of monitoring antiretroviral treatment","volume":"137","author":"M Gandhi","year":"2002"},{"key":"ref5","first-page":"455","article-title":"Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers","volume":"42","author":"KR Amico","year":"2006"},{"key":"ref6","first-page":"1417","article-title":"Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring","volume":"33","author":"JH Arnsten","year":"2001"},{"key":"ref7","first-page":"968","article-title":"A comparison study of multiple measures of adherence to HIV protease inhibitors","volume":"134","author":"H Liu","year":"2001"},{"issue":"Suppl 1","key":"ref8","first-page":"S79","article-title":"Practical and conceptual challenges in measuring antiretroviral adherence","volume":"43","author":"KM Berg","year":"2006"},{"key":"ref9","first-page":"386","article-title":"Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response","volume":"33","author":"M Duong","year":"2001"},{"key":"ref10","first-page":"53","article-title":"Can urine lamivudine be used to monitor antiretroviral treatment adherence?","volume":"8","author":"AK Kumar","year":"2006"},{"key":"ref11","first-page":"471","article-title":"Protease inhibitor levels in hair strongly predict virologic response to treatment","volume":"23","author":"M Gandhi","year":"2009"},{"key":"ref12","first-page":"3401","article-title":"Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry","volume":"22","author":"Y Huang","year":"2008"},{"key":"ref13","first-page":"161","article-title":"Hair analysis for abused and therapeutic drugs","volume":"733","author":"Y Nakahara","year":"1999"},{"key":"ref14","first-page":"283","article-title":"Pharmacological studies on meprobamate incorporation in human beard hair","volume":"105","author":"P Kintz","year":"1993"},{"key":"ref15","first-page":"3328","article-title":"Determination of gestational cocaine exposure by hair analysis","volume":"262","author":"K Graham","year":"1989"},{"key":"ref16","first-page":"656","article-title":"Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy","volume":"137","author":"L Bernard","year":"2002"},{"key":"ref17","first-page":"333","article-title":"Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting","volume":"56","author":"GU van Zyl","year":"2011"},{"key":"ref18","first-page":"e0129100","article-title":"Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients","volume":"10","author":"SM Baxi","year":"2015"},{"key":"ref19","article-title":"<italic>China Free ART Manual<\/italic>","author":"F Z","year":"2005"},{"key":"ref20","article-title":"<italic>China Free ART Manual<\/italic>","author":"F Zhang","year":"2008"},{"key":"ref21","first-page":"2097","article-title":"Reductions in virological failure and drug resistance in Chinese antiretroviral-treated patients due to lamivudine-based regimens, 2003\u201312","volume":"70","author":"H Xing","year":"2015"},{"key":"ref22","first-page":"451","article-title":"Pharmacokinetics of lamivudine &amp; stavudine in generic fixed-dose combinations in HIV-1 infected adults in India","volume":"130","author":"AK Hemanth Kumar","year":"2009"},{"issue":"Suppl 1","key":"ref23","first-page":"S5","article-title":"Therapeutic drug monitoring in HIV infection: current status and future directions","volume":"16","author":"D Back","year":"2002"},{"key":"ref24","first-page":"441","article-title":"Correlation between lamivudine plasma concentrations and patient self-reported adherence to antiretroviral treatment in experienced HIV patients","volume":"7","author":"O Minzi","year":"2011"},{"key":"ref25","first-page":"1019","article-title":"Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART","volume":"63","author":"X Panhard","year":"2007"},{"key":"ref26","first-page":"176","article-title":"Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice daily","volume":"48","author":"GJ Yuen","year":"2004"},{"key":"ref27","first-page":"1923","article-title":"Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry","volume":"401","author":"Y Huang","year":"2011"},{"key":"ref28","first-page":"1267","article-title":"Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy","volume":"52","author":"M Gandhi","year":"2011"},{"key":"ref29","first-page":"103","article-title":"Factors associated with HIV virologic failure among patients on HAART for one year at three sentinel surveillance sites in China","volume":"9","author":"X Wang","year":"2011"},{"key":"ref30","first-page":"1357","article-title":"Virologic outcomes of first-line HAART and associated factors among Chinese patients with HIV in three sentinel antiretroviral treatment sites","volume":"15","author":"Y Ruan","year":"2010"},{"key":"ref31","first-page":"110","article-title":"The role of variations in growth rate and sample collection on interpreting results of segmental analyses of hair","volume":"210","author":"MA LeBeau","year":"2011"},{"key":"ref32","first-page":"951","article-title":"Resisting resistance: maximizing the durability of antiretroviral therapy","volume":"128","author":"JH Condra","year":"1998"},{"key":"ref33","first-page":"e005886","article-title":"HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China","volume":"4","author":"X Leng","year":"2014"},{"key":"ref34","first-page":"e54917","article-title":"HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patients","volume":"8","author":"H Xing","year":"2013"},{"key":"ref35","unstructured":"WHO global strategy for the surveillance and monitoring of HIV drug resistance 2012. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/drugresistance\/drug_resistance_strategy\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/pub\/drugresistance\/drug_resistance_strategy\/en\/<\/ext-link>. Accessed 2014 April 30."},{"key":"ref36","first-page":"1115","article-title":"The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials","volume":"34","author":"S Mannheimer","year":"2002"},{"key":"ref37","first-page":"25","article-title":"Short communication: A low-cost method for analyzing nevirapine levels in hair as a marker of adherence in resource-limited settings","volume":"30","author":"M Gandhi","year":"2014"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0154421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:05:11Z","timestamp":1588968311000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0154421"}},"subtitle":[],"editor":[{"given":"Shibo","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,27]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0154421","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,27]]}}}